BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22111827)

  • 21. Bacterial colonization in hemodialysis temporary dual lumen catheters: a prospective study.
    de Freitas LW; Neto MM; Nascimento MM; Figueiredo JF
    Ren Fail; 2008; 30(1):31-5. PubMed ID: 18197540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nasal carriage of Staphylococcus aureus in families of children on peritoneal dialysis. European Pediatric Peritoneal Dialysis Study Group (EPPS).
    Oh J; von Baum H; Klaus G; Schaefer F
    Adv Perit Dial; 2000; 16():324-7. PubMed ID: 11045321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cefotaxime-heparin lock prophylaxis against hemodialysis catheter-related sepsis among Staphylococcus aureus nasal carriers.
    Saxena AK; Panhotra BR; Al-hafiz AA; Sundaram DS; Abu-Oyun B; Al Mulhim K
    Saudi J Kidney Dis Transpl; 2012 Jul; 23(4):743-54. PubMed ID: 22805387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staphylococcus aureus nasal carriage in children receiving long-term peritoneal dialysis.
    Kingwatanakul P; Warady BA
    Adv Perit Dial; 1997; 13():281-4. PubMed ID: 9360700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Surveillance for bacteremia related to vascular access in hemodialysis].
    Ferrero S; Saltarelli M; Quori A; Campobasso M; Argentero PA
    G Ital Nefrol; 2008; 25(3):347-53. PubMed ID: 18473306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of nasal mupirocin for Staphylococcus aureus: effect on nasal carriers and nosocomial infections].
    García AM; Villa MV; Escudero ME; Gómez P; Vélez MM; Múnera MI; Franco G
    Biomedica; 2003 Jun; 23(2):173-9. PubMed ID: 12872556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation of Staphylococcus aureus nasal and skin carriage among patients undergoing haemodialysis treatment.
    Bogut A; Kozioł-Montewka M; Baranowicz I; Jóźwiak L; Ksiazek A; Al-Doori Z; Morrison D; Kaczor D; Paluch-Oleś J
    New Microbiol; 2007 Apr; 30(2):149-54. PubMed ID: 17619259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group.
    von Eiff C; Becker K; Machka K; Stammer H; Peters G
    N Engl J Med; 2001 Jan; 344(1):11-6. PubMed ID: 11136954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elimination of Staphylococcus aureus in hemodialysis patients.
    Bommer J; Vergetis W; Andrassy K; Hingst V; Borneff M; Huber W
    ASAIO J; 1995; 41(1):127-31. PubMed ID: 7727815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of gram-positive coccal bacteremia and hemodialysis.
    Fitzgibbons LN; Puls DL; Mackay K; Forrest GN
    Am J Kidney Dis; 2011 Apr; 57(4):624-40. PubMed ID: 21333430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
    Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
    Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of resistance in staphylococci after long-term mupirocin application in patients on continuous ambulatory peritoneal dialysis.
    Cavdar C; Atay T; Zeybel M; Celik A; Ozder A; Yildiz S; Gulay Z; Camsari T
    Adv Perit Dial; 2004; 20():67-70. PubMed ID: 15384798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low colonization prevalence of Staphylococcus aureus with reduced vancomycin susceptibility among patients undergoing hemodialysis in the San Francisco Bay area.
    Eguia JM; Liu C; Moore M; Wrone EM; Pont J; Gerberding JL; Chambers HF
    Clin Infect Dis; 2005 Jun; 40(11):1617-24. PubMed ID: 15889359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epidemiology and prevention of Staphylococcus aureus infections during hemodialysis].
    Boelaert JR; Van Landuyt HW; De Baere YA; Gheyle DW; Daneels RF; Schurgers ML; Matthys EG; Gordts BZ
    Nephrologie; 1994; 15(2):157-61. PubMed ID: 8047204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The treatment of Staphylococcus aureus nasal carriage in pediatric peritoneal dialysis patients.
    Blowey DL; Warady BA; McFarland KS
    Adv Perit Dial; 1994; 10():297-9. PubMed ID: 7999849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factor analysis for long-term tunneled dialysis catheter-related bacteremias.
    Jean G; Charra B; Chazot C; Vanel T; Terrat JC; Hurot JM; Laurent G
    Nephron; 2002 Jul; 91(3):399-405. PubMed ID: 12119469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.
    Chang FY; Peacock JE; Musher DM; Triplett P; MacDonald BB; Mylotte JM; O'Donnell A; Wagener MM; Yu VL
    Medicine (Baltimore); 2003 Sep; 82(5):333-9. PubMed ID: 14530782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates.
    Paterson DL; Rihs JD; Squier C; Gayowski T; Sagnimeni A; Singh N
    Transplantation; 2003 Jan; 75(2):194-8. PubMed ID: 12548122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of haemodialysis and peritoneal dialysis catheter related infection by topical povidone-iodine.
    Fong IW
    Postgrad Med J; 1993; 69 Suppl 3():S15-7. PubMed ID: 8290450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Staphylococcus aureus infections in dialysis patients: focus on prevention.
    Piraino B
    ASAIO J; 2000; 46(6):S13-7. PubMed ID: 11110288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.